Fig. 2From: Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trialComparison of time to progression between the sorafenib group (solid line) and the HAIC group (dotted line). HAIC, hepatic arterial infusion chemotherapyBack to article page